PHE patient group direction (PGD) template – administration of typhoid Vi polysaccharide vaccine to overseas travellers at risk of exposure to Salmonella enterica serovar typhi (S. typhi)

PHE Have published a patient group direction (PGD) template which supports the administration of typhoid Vi polysaccharide vaccine to overseas travellers at risk of exposure to Salmonella enterica serovar typhi (S. typhi) in accordance with recommendations from the National Travel Health Network and Centre (NaTHNaC).

It is valid from 1 March 2018 to 29 February 2020.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012).

Practitioners should follow local policy and procedures to access authorised PGD documents. This PGD template should be used with reference to current national guidance, Green Book, and Summary of Product Characteristics for the vaccine.   Patient group direction (PGD) template supports the administration of typhoid Vi polysaccharide vaccine to overseas travellers at risk of exposure to Salmonella enterica serovar typhi (S. typhi) in accordance with recommendations from the National Travel Health Network and Centre (NaTHNaC).

https://www.gov.uk/government/publications/typhoid-vi-vaccine-patient-group-direction

 

 

Community Health ServicesNewsPatient Group DirectionsPrimary CareTravel MedicineVaccination